Navigation Links
Man who Lost Everything Comes to Detroit to Spread Message of Hope
Date:5/20/2008

Recovery is Possible!

DETROIT, Mich., May 19 /PRNewswire-USNewswire/ -- Patrick Hendry lost his career, home, wife and his sense of self because of bipolar disorder. He spent seven years in and out of the hospital, trying every medication available. He was desperate; he even went so far as trying electro-convulsive therapy, similar to shock therapy.

"That was a confusing, scary and trying time in my life. You feel hopeless and lost," said Hendry. "It's difficult to figure out what to do or where to go next."

After years of frustration, doctor's visits and lots of different medications, he began to understand the disorder and that's when he decided to begin working as a mental health advocate after 16 years as a gem dealer and prior to that, a filmmaker. "That's when I got back control of my life," said Hendry. "So it's only fitting that I come to this one-of-a-kind international conference being held in Detroit and tell my story!"

Hendry, along with 100 panelists and moderators and 800 attendees, will be in Detroit next week, attending the International Conference on Self-Determination, May 27-28th at the GM Marriott located in the Renaissance Center. Hendry is a panelist in a session related to budgeting, fiscal management and peer supports.

"I want people to know that recovery is possible and that people need to understand how to be in charge of their lives and how to take control," said Hendry who is now the Executive Director of the Florida Peer Network, a non-profit for people with psychiatric disabilities and disorders. "Self-direction should be the primary way that we provide mental health care in the United States. "The combination of choice, independence, responsibility and self-esteem is invaluable in recovery."

Hendry has also just edited and published a book telling the stories of recovery of many Florida residents.

There is still time to register for this cross-disability, precedent-setting confe
'/>"/>

SOURCE Community Living Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. When It Comes to Pregnancy, Timing Is Everything
2. Is a cup of tea really the answer to everything -- even anthrax?
3. Understanding the have-knots: The role of stress in just about everything
4. For the fruit fly, everything changes after sex
5. Wanting a bite of everything: Hungry people crave more variety
6. With age comes a sense of peace and calm
7. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
8. With age comes a sense of peace and calm, population research center study shows
9. Outcomes Similar for Laparoscopic, Open Colon Cancer Surgeries
10. Study suggests blood test can help improve treatment outcomes for breast cancer patients
11. AUA 2008: Access to urologists and prostate cancer screenings lead to better outcomes for patients
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 2Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 3Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 4Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 5Phase III CONFIRM Study Shows FASLODEX(R) (fulvestrant) Injection 500 mg May Delay Time of Disease Progression Over 250-mg Dose in Postmenopausal Women With Hormone Receptor-Positive Advanced Breast Cancer 6Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 1Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 2Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 3Crohn 26apos 3Bs 26amp 3B Colitis Foundation Encourages More Virtual Event Participants 3A Thousands Already Helped Foundation Raise Funds for Resear 57790 4Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics 28TCT 29 2009 57787 1Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics 28TCT 29 2009 57787 2Novel Information about Vulnerable Coronary Artery Plaque to be Presented at Transcatheter Cardiovascular Therapeutics 28TCT 29 2009 57787 3Osseon Receives CE Mark 57784 1Osseon Receives CE Mark 57784 2